Previous 10 | Next 10 |
IQVIA™ (NYSE: IQV) today announced that Nancy Dreyer, chief scientific officer and senior vice president, Real World Solutions, has been awarded PharmaVOICE magazine’s Red Jacket honor after she was recognized multiple times as a PharmaVOICE 100. IQVIA’s Deepa Desai, vi...
The average amount paid out-of-pocket per prescription remains steady at $10.67, unchanged from 2018 and up only $0.33 since 2014, as high levels of generic drug use and greater use of manufacturer coupons offset higher costs A record share of branded prescriptions is being dispense...
Orchestrate intelligent and agile strategies for personalized customer engagement IQVIA™ (NYSE: IQV) today introduced OCE Optimizer , an innovative solution that empowers life sciences companies to plan and refine marketing engagements with healthcare providers (HCPs) on demand...
IQVIA Holdings Inc. (IQV) Q2 2020 Earnings Conference Call July 22, 2020, 09:00 AM ET Company Participants Andrew Markwick - SVP, IR and Treasury Ari Bousbib - Chairman and CEO Michael McDonnell - EVP and CFO Eric Sherbet - EVP and General Counsel Nick Childs - SVP, Financial...
The following slide deck was published by IQVIA Holdings Inc. in conjunction with their 2020 Q2 earnings Read more ...
IQVIA ( IQV ) Q2 results : More news on: IQVIA Holdings Inc., Healthcare stocks news, Earnings news and commentary, , Stocks on the move, Read more ...
IQVIA (NYSE: IQV ) : Q2 Non-GAAP EPS of $1.18 beats by $0.12 ; GAAP EPS of -$0.12 misses by $0.04 . More news on: IQVIA Holdings Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Second quarter revenue $2,521 million and Adjusted EBITDA $483 million GAAP Diluted Earnings per Share $(0.12); Adjusted Diluted Earnings per Share $1.18 R&D Solutions quarterly net book-to-bill ratio 1.64x including pass throughs and 1.60x excluding pass throughs; contra...
CAMBRIDGE, Mass., July 21, 2020 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today the appointment of Michael (Mike) McDonnell as Executive Vice President and Chief Financial Officer, effective August 15, 2020. McDonnell joins Biogen from IQVIA™ (NYSE: IQV), where he ...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and contract services to the life sciences industry, today announced the appointment of Ron Bruehlman as Executive Vice President and interim Chief Financial Officer,...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...